Ahmet KARADENİZ, Kamuran İBİŞ, Rasim MERAL, Murat GÜVELİ, Selnur ÖZKURT, Bilge BİLGİÇ, Musa ALTUN

Different Central Localizations, Different Histopathologies, Benefits, and Side Effects of Radiotherapy in Neurocytoma

OBJECTIVE Neurocytoma is a rare tumor of central nervous system (CNS). The present study is an analysis of benefits and risks of radiotherapy (RT) after surgery. METHODS Following a retrospective evaluation of 2186 CNS tumors treated at the university oncology institute, 6 cases of neurocytoma were found. These 6 cases were analyzed according to patient sex, age, location of tumor, treatment type, and survival. RESULTS Median patient age was 40 years. Four tumors were centrally located, and the remaining 2 tumors were located in the extraventricular region. All of the patients received 50–60 Gy of conventional irradiation. Median length of follow-up was 51 months (range: 15–88 months). In this study, 5-year survival rate was 60%. CONCLUSION Primary treatment for neurocytoma is surgery. RT is suggested only for subtotally resected tumors, recurrent tumors, or tumors with atypical characteristics due to delayed side effects.

PDF

___

1. Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, et al. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 1982;56(2):151–6.
2. Bertalanffy A, Roessler K, Dietrich W, Aichholzer M, Prayer D, Ertl A, et al. Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry 2001;70(4):489–93.
3. Chen CL, Shen CC, Wang J, Lu CH, Lee HT. Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin Neurol Neurosurg 2008;110(2):129–36.
4. Choudhari KA, Kaliaperumal C, Jain A, Sarkar C, Soo MY, Rades D, et al. Central neurocytoma: a multi-disciplinary review. Br J Neurosurg 2009;23(6):585–95.
5. Sharma MC, Deb P, Sharma S, Sarkar C. Neurocytoma: a comprehensive review. Neurosurg Rev 2006;29(4):270–85.
6. Matsunaga S, Shuto T, Suenaga J, Inomori S, Fujino H. Gamma knife radiosurgery for central neurocytomas. Neurol Med Chir (Tokyo) 2010;50(2):107–13.
7. Yarsagil MG, von Ammon K, von Deimling A, Valavanis A, Wichmann W, Wiestler OD. Central neurocytoma: histopathological variants and therapeutic approach. J Neurosurg 1992;76:32–7.
8. Rades D, Schild SE, Fehlauer F. Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 2004;62(6):987–9.
9. Hassoun J, Söylemezoglu F, Gambarelli D, FigarellaBranger D, von Ammon K, Kleihues P. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 1993;3(3):297–306.
10. Shah T, Jayasundar R, Singh VP, Sarkar C. MRS characterization of central neurocytomas using glycine. NMR Biomed 2011;24(10):1408–13.
11.Rades D, Schild SE. Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 2006;77(3):305–9.
12.Rades D, Fehlauer F, Schild SE. Treatment of atypical neurocytomas. Cancer 2004;100(4):814–7.
13.Ashkan K, Casey AT, D’Arrigo C, Harkness WF, Thomas DG. Benign central neurocytoma. Cancer 2000;89:1111–20.
14.Kapoor N, Gandhi A, Chaurasia AK. Central neurocytoma in the vermis of the cerebellum. Indian J Pathol Microbiol 2009;52(1):108–9.
15. Vasiljevic A, François P, Loundou A, Fèvre-Montange M, Jouvet A, Roche PH, et al. Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 2012;36(2):220–7.
16. Leenstra JL, Rodriguez FJ, Frechette CM, Giannini C, Stafford SL, Pollock BE, et al. Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 2007;67(4):1145–54.
17.Rades D, Fehlauer F. Treatment options for central neurocytoma. Neurology 2002;59(8):1268–70.
18.Nishio S, Takeshita I, Kaneko Y, Fukui M. Cerebral neurocytoma. A new subset of benign neuronal tumors of the cerebrum. Cancer 1992;70(2):529–37.
19.Brat DJ, Scheithauer BW, Eberhart CG, Burger PC. Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 2001;25(10):1252–60.
20. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2):97–109.
21. Sweiss FB, Lee M, Sherman JH. Extraventricular neurocytomas. Neurosurg Clin N Am 2015;26(1):99–104.
22.Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Lehil M, et al. Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg 2012;116(2):349–54.
23.Xiong Z, Zhang J, Li Z, Jiang J, Han Q, Sun S, et al. A comparative study of intraventricular central neurocytomas and extraventricular neurocytomas. J Neurooncol 2015;121(3):521–9.
24.Anderson RC, Elder JB, Parsa AT, Issacson SR, Sisti MB. Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery 2001;48(6):1231–8
25.Rades D, Schild SE. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer 2006;106(5):1140–3.
26.Rades D, Fehlauer F, Schild S, Lamszus K, Alberti W. Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients. [Article in German] Strahlenther Onkol 2003;179(4):213–8. [Abstract]
27. Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, et al. Central neurocytomas. Cancer 1997;79(4):790–5.
28.Rades D, Schild SE, Ikezaki K, Fehlauer F. Defining the optimal dose of radiation after incomplete resection of central neurocytomas. Int J Radiat Oncol Biol Phys 2003;55(2):373–7.
29. Park HK, Steven D C. Stereotactic radiosurgery for central neurocytoma: a quantitative systematic review. J Neurooncol 2012;108(1):115–21.
30. Eng DY, DeMonte F, Ginsberg L, Fuller GN, Jaeckle K. Craniospinal dissemination of central neurocytoma. Report of two cases. J Neurosurg 1997;86(3):547–52.
31.Metellus P, Dufour H, Fuentes S, Do L, Figarella-Branger D, Grisoli F. Central neurocytoma revealed by intraventricular hemorrhage. A case report and review of the literature. Neurochirurgie 2001;47(4):445–7.
32. Söylemezoglu F, Scheithauer BW, Esteve J, Kleihues P. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997;56(5):551–6.
33.Christov C, Adle-Biassette H, Le Guerinel C. Recurrent central neurocytoma with marked increase in MIB-1 labelling index. Br J Neurosurg 1999;13(5):496–9.
34.Kaur G, Kane AJ, Sughrue ME, Oh M, Safaee M, Sun M, et al. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas. J Clin Neurosci 2013;20(1):89–93.
35.Ogawa Y, Sugawara T, Seki H, Sakuma T. Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination. J Neurooncol 2006;79(2):211–6.
36. Paek SH, Han JH, Kim JW, Park CK, Jung HW, Park SH, et al. Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol 2008;90(1):25–30.
37.Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD. Radiation-induced brain injury: A review. Front Oncol 2012;2:73.
38.Butler JM, Rapp SR, Shaw EG. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol 2006;7(6):517–23.
39.Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 2011;6:48.
40.Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 2011;105(2):423–31.
41.Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review. Cancer Invest 1989;7(3):287–94.
42.Remler MP, Marcussen WH, Tiller-Borsich J. The late effects of radiation on the blood brain barrier. Int J Radiat Oncol Biol Phys 1986;12(11):1965–9.
43.Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007;67(2):323–6.
44.Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994;44(11):2020–7.
45.McPherson CM, Warnick RE. Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 2004;68(1):41–7.
46.Tye K, Engelhard HH, Slavin KV, Nicholas MK, Chmura SJ, Kwok Y, et al. An analysis of radiation necrosis of the central nervous system treated with bevacizumab. J Neurooncol 2014;117(2):321–7.